FDA · EMA · PMDA · ISO · ICH
Regulatory Insights
What regulators expect and what is changing, with practical guides, checklists and templates for quality and regulatory teams in medical devices and pharma.
4 reports · 94 guides
Deep Research reports
- FDA QMSR 2026: What Warning Letters Reveal About Medical Device Quality Failures What FDA inspects under the QMSR since February 2, 2026, and what device warning letters show about internal audits, suppliers, management review and CAPA.
- The Hidden Regulatory Risks Behind the GLP-1 Boom: Evidence from FDA Warning Letters What FDA warning letters from 2024 to 2026 show about compounded semaglutide and tirzepatide, misleading telehealth claims and unapproved peptides.
- Why Sterile Drug Manufacturing Keeps Failing: Lessons from FDA Warning Letters What FDA warning letters show about smoke studies, media fills, environmental monitoring, OOS retests and quality unit failures in sterile drug plants.
- Why CAPA Fails: Recurring Quality Problems in FDA Warning Letters What FDA warning letters from 2017 to 2026 show about CAPA triggers, root cause analysis, effectiveness checks, other-batch investigations and risk files.
Latest guides
- Regulatory Gap Analysis and Impact Assessment: A Practical Method for Life Sciences How to run a regulatory gap analysis in life sciences, with QMSR, EU reform and Annex 11 examples, how it differs from a government RIA, and a template.
- Regulatory Submission Management and Automation: eCTD, Tools and What to Automate How regulatory submissions are planned, assembled and published: eCTD 4.0 and eSTAR timelines, submission software, what to automate and AI review.
- RIM Software: Regulatory Information and Document Management Explained What regulatory information management (RIM) software does, how it differs from document management, why IDMP and eCTD 4.0 matter, and how to choose.
- Regulatory Intelligence: Sources, Process, Software and the Role of AI What regulatory intelligence is, the three parts of a mature RI function, what to look for in RI software, and where AI helps and where it does not.
- Regulatory Change Management: How to Monitor and Act on Regulatory Changes How to monitor regulatory changes and act on them: sources, triage, impact assessment and tracking, with 2025-2026 examples from FDA, EMA and the EU.
- Regulatory Compliance Management for Life Sciences: Building a System That Holds Up How life sciences companies manage regulatory compliance as a system: obligations registers, controls, monitoring, inspection readiness and evidence.
Regulatory Affairs & Intelligence
All 18 →Regulatory submissions, gap and impact analysis, regulatory document review and keeping up with regulatory change.
- Medical Device Regulatory Affairs in 2026: Role, Responsibilities and Trends
- Medical Device Regulatory Software: RIM, Submissions and Regulatory Intelligence Tools
- Regulatory Affairs in Life Sciences: What the Function Does and How It Is Changing
- Regulatory Compliance Management for Life Sciences: Building a System That Holds Up
- Regulatory Change Management: How to Monitor and Act on Regulatory Changes
- Regulatory Intelligence: Sources, Process, Software and the Role of AI
- RIM Software: Regulatory Information and Document Management Explained
- Regulatory Submission Management and Automation: eCTD, Tools and What to Automate
FDA, ISO 13485 & EU MDR
All 34 →Inspection readiness, FDA 483s and warning letters, QMSR, ISO 13485 audits and EU MDR technical documentation.
- QMSR Compliance Software: What Medical Device Makers Need After the FDA's 2026 Transition
- FDA QMSR Checklist: An ISO 13485 Gap Analysis for U.S. Device Makers
- EU MDR Technical Documentation Checklist: Annex II, Annex III and the GSPR Matrix
- FDA 483 Response Checklist: How to Answer Observations in 15 Business Days
- ISO 13485 Internal Audit Checklist: QMSR-Ready for 2026
- ISO 13485 in 2026: Requirements, QMSR Alignment and Compliance Guide
- EU MDR in 2026: Deadlines, the Simplification Proposal and a Compliance Roadmap
- FDA Form 483 Explained: What It Means, Top Observations and How to Respond
Pharma & GMP
All 37 →Pharmaceutical quality assurance, GMP and GxP compliance, data integrity and inspection readiness.
- GMP Data Integrity Checklist: ALCOA+, Audit Trails and 2026 Expectations
- ICH Q9(R1) Quality Risk Management Template: What Changed and How to Apply It
- What Is GMP? Good Manufacturing Practice Explained for 2026
- Pharmaceutical Manufacturing in 2026: Onshoring, Advanced Manufacturing and What FDA Expects
- GxP Compliance: What GMP, GLP, GCP and GDP Require and How to Stay Compliant
- GMP Compliance and GMP Inspections: What FDA Investigators Look For in Drug Facilities
- GMP and GxP Software: Validation, Data Integrity and Automation in 2026
- GMP Audits: How to Plan and Run Internal, Supplier and Mock Inspection Audits
Medical Devices
All 41 →Quality management, regulatory compliance and documentation review across the medical device lifecycle.
- ISO 14971 Risk Management Checklist: What FDA Inspectors Look for in 2026
- Medical Device Manufacturing in 2026: Regulations, Tariffs and Automation
- Medical Device Compliance in 2026: An FDA and EU Regulatory Compliance Guide
- Medical Device Regulations Explained: FDA Classes, Pathways and 2026 Updates
- Medical Device Automation: Validating Automated Manufacturing and QA Under QMSR
- Medical Device Compliance Software: A 2026 Buyer's Guide to Quality Management Tools
- Medical Device Certification Explained: FDA Clearance, CE Marking and ISO 13485
- Medical Device Audits in 2026: Internal, Supplier, Notified Body and MDSAP